Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-influenza Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
GlaxoSmithKline
Guangzhou Pharmaceutical
Hunan Nucien Pharmaceutical
HEC Pharm
Roche
By Type:
Zanamivir
Other
Oseltamivir
Peramivir
By Application:
Adults
Children
Elderly
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anti-influenza Drugs Market Overview 2018-2029
-
1.1 China Anti-influenza Drugs Industry Development Overview
-
1.2 China Anti-influenza Drugs Industry Development History
-
1.3 China Anti-influenza Drugs Industry Market Size (2018-2029)
-
1.4 China Anti-influenza Drugs Market Analysis by Type from Production Side
-
1.4.1 China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Zanamivir (2018-2029)
-
1.4.2 China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.3 China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Oseltamivir (2018-2029)
-
1.4.4 China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Peramivir (2018-2029)
-
1.5 China Anti-influenza Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Anti-influenza Drugs Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)
-
1.5.2 China Anti-influenza Drugs Sales Volume, Sales Value and Growth Rate of Children (2018-2029)
-
1.5.3 China Anti-influenza Drugs Sales Volume, Sales Value and Growth Rate of Elderly (2018-2029)
-
1.6 China Anti-influenza Drugs Market Analysis by Region
-
1.6.1 North China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Anti-influenza Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anti-influenza Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anti-influenza Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Anti-influenza Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anti-influenza Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anti-influenza Drugs Industry Development
Chapter 3 Anti-influenza DrugsIndustry Chain Analysis
-
3.1 Anti-influenza Drugs Industry Chain
-
3.2 Anti-influenza Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anti-influenza Drugs Market
-
3.3 Anti-influenza Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anti-influenza Drugs Market
Chapter 4 China Anti-influenza Drugs Market, by Type
-
4.1 China Anti-influenza Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anti-influenza Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Anti-influenza Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Anti-influenza Drugs Production Volume and Growth Rate of Zanamivir
-
4.5.2 China Anti-influenza Drugs Production Volume and Growth Rate of Other
-
4.5.3 China Anti-influenza Drugs Production Volume and Growth Rate of Oseltamivir
-
4.5.4 China Anti-influenza Drugs Production Volume and Growth Rate of Peramivir
Chapter 5 China Anti-influenza Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anti-influenza Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Anti-influenza Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Anti-influenza Drugs Market Size and Growth Rate of Adults
-
5.5.2 China Anti-influenza Drugs Market Size and Growth Rate of Children
-
5.5.3 China Anti-influenza Drugs Market Size and Growth Rate of Elderly
Chapter 6 China Anti-influenza Drugs Market, by Region
-
6.1 China Anti-influenza Drugs Production Volume and Production Value, by Region
-
6.2 China Anti-influenza Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Anti-influenza Drugs Market Analysis
-
7.1 North China Anti-influenza Drugs Market, by Type
-
7.2 North China Anti-influenza Drugs Market, by Application
Chapter 8 Central China Anti-influenza Drugs Market Analysis
-
8.1 Central China Anti-influenza Drugs Market, by Type
-
8.2 Central China Anti-influenza Drugs Market, by Application
Chapter 9 South China Anti-influenza Drugs Market Analysis
-
9.1 South China Anti-influenza Drugs Market, by Type
-
9.2 South China Anti-influenza Drugs Market, by Application
Chapter 10 East China Anti-influenza Drugs Market Analysis
-
10.1 East China Anti-influenza Drugs Market, by Type
-
10.2 East China Anti-influenza Drugs Market, by Application
Chapter 11 Northeast China Anti-influenza Drugs Market Analysis
-
11.1 Northeast China Anti-influenza Drugs Market, by Type
-
11.2 Northeast China Anti-influenza Drugs Market, by Application
Chapter 12 Southwest China Anti-influenza Drugs Market Analysis
-
12.1 Southwest China Anti-influenza Drugs Market, by Type
-
12.2 Southwest China Anti-influenza Drugs Market, by Application
Chapter 13 Northwest China Anti-influenza Drugs Market Analysis
-
13.1 Northwest China Anti-influenza Drugs Market, by Type
-
13.2 Northwest China Anti-influenza Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Profile
-
14.1.2 GlaxoSmithKline Anti-influenza Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Guangzhou Pharmaceutical
-
14.2.1 Guangzhou Pharmaceutical Company Profile
-
14.2.2 Guangzhou Pharmaceutical Anti-influenza Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Hunan Nucien Pharmaceutical
-
14.3.1 Hunan Nucien Pharmaceutical Company Profile
-
14.3.2 Hunan Nucien Pharmaceutical Anti-influenza Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 HEC Pharm
-
14.4.1 HEC Pharm Company Profile
-
14.4.2 HEC Pharm Anti-influenza Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Roche
-
14.5.1 Roche Company Profile
-
14.5.2 Roche Anti-influenza Drugs Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anti-influenza Drugs Industry Research Conclusions
-
15.2 Anti-influenza Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anti-influenza Drugs Industry Market Size (2018-2029)
-
Figure China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Zanamivir (2018-2029)
-
Figure China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Oseltamivir (2018-2029)
-
Figure China Anti-influenza Drugs Production Volume, Production Value and Growth Rate of Peramivir (2018-2029)
-
Figure China Anti-influenza Drugs Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)
-
Figure China Anti-influenza Drugs Sales Volume, Sales Value and Growth Rate of Children (2018-2029)
-
Figure China Anti-influenza Drugs Sales Volume, Sales Value and Growth Rate of Elderly (2018-2029)
-
Figure North China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anti-influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Anti-influenza Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anti-influenza Drugs Market Share by Type in 2018
-
Figure China Anti-influenza Drugs Market Share by Type in 2023
-
Figure China Anti-influenza Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anti-influenza Drugs Production Volume and Growth Rate of Zanamivir (2018-2023)
-
Figure China Anti-influenza Drugs Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Anti-influenza Drugs Production Volume and Growth Rate of Oseltamivir (2018-2023)
-
Figure China Anti-influenza Drugs Production Volume and Growth Rate of Peramivir (2018-2023)
-
Figure China Anti-influenza Drugs Market Share by Application in 2018
-
Figure China Anti-influenza Drugs Market Share by Application in 2023
-
Figure China Anti-influenza Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Anti-influenza Drugs Market Size and Growth Rate of Adults (2018-2023)
-
Figure China Anti-influenza Drugs Market Size and Growth Rate of Children (2018-2023)
-
Figure China Anti-influenza Drugs Market Size and Growth Rate of Elderly (2018-2023)
-
Table China Anti-influenza Drugs Production Volume by Region (2018-2023)
-
Table China Anti-influenza Drugs Production Volume Share by Region (2018-2023)
-
Figure China Anti-influenza Drugs Production Volume Share by Region (2018-2023)
-
Table China Anti-influenza Drugs Production Value by Region (2018-2023)
-
Table China Anti-influenza Drugs Production Value Share by Region (2018-2023)
-
Figure China Anti-influenza Drugs Production Value Share by Region (2018-2023)
-
Table China Anti-influenza Drugs Sales Volume by Region (2018-2023)
-
Table China Anti-influenza Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Anti-influenza Drugs Sales Volume Share by Region (2018-2023)
-
Table China Anti-influenza Drugs Sales Value by Region (2018-2023)
-
Table China Anti-influenza Drugs Sales Value Share by Region (2018-2023)
-
Figure China Anti-influenza Drugs Sales Value Share by Region (2018-2023)
-
Table North China Anti-influenza Drugs Production Volume by Type (2018-2023)
-
Table North China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Table North China Anti-influenza Drugs Sales Volume by Application (2018-2023)
-
Table North China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Anti-influenza Drugs Production Volume by Type (2018-2023)
-
Table Central China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Anti-influenza Drugs Sales Volume by Application (2018-2023)
-
Table Central China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Anti-influenza Drugs Production Volume by Type (2018-2023)
-
Table South China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Table South China Anti-influenza Drugs Sales Volume by Application (2018-2023)
-
Table South China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Anti-influenza Drugs Production Volume by Type (2018-2023)
-
Table East China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Table East China Anti-influenza Drugs Sales Volume by Application (2018-2023)
-
Table East China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anti-influenza Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Anti-influenza Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anti-influenza Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Anti-influenza Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anti-influenza Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anti-influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Anti-influenza Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anti-influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Anti-influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Guangzhou Pharmaceutical Company Profile
-
Table Guangzhou Pharmaceutical Anti-influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Hunan Nucien Pharmaceutical Company Profile
-
Table Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table HEC Pharm Company Profile
-
Table HEC Pharm Anti-influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Anti-influenza Drugs Revenue, Price and Gross (2018-2023)
-
